Login to Your Account

Pharma: Clinic Roundup

Tuesday, August 27, 2013
Sanofi Pasteur SA, of Lyon, France, disclosed top-line results of a large-scale, multicenter efficacy trial in people 65 years of age and older showing a superior clinical benefit of Fluzone high-dose flu vaccine relative to the standard dose of Fluzone vaccine in preventing influenza.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription